🇯🇵 Incruse Ellipta in Japan

PMDA authorised Incruse Ellipta on 4 July 2014

Marketing authorisation

PMDA — authorised 4 July 2014

  • Marketing authorisation holder: GLAXOSMITHKLINE K.K.
  • Status: approved

Incruse Ellipta in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Respiratory approved in Japan

Frequently asked questions

Is Incruse Ellipta approved in Japan?

Yes. PMDA authorised it on 4 July 2014.

Who is the marketing authorisation holder for Incruse Ellipta in Japan?

GLAXOSMITHKLINE K.K. holds the Japanese marketing authorisation.